Clinical trials: Menstrual Cramp

Endometriosis

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

• Terminated
• Age: 18 to 50 years
• Phase 3
• Pill or oral medicine
• Results posted

The primary objective of this extension study is to assess the maintenance of efficacy of linzagolix administered orally once daily for up to an additional 6 months (for up to 12 months of treatment in total) in women who have…

Trial name

EDELWEISS 5 (NCT04372121)

Testing

75 mg linzagolix tablet, 200 mg linzagolix tablet, Add-back capsule (E2 1 mg / NETA 0.5 mg)

Where

25 sites in United States, Canada and 1 more

Volunteers

30 people

Sponsor

Kissei Pharmaceutical Co., Ltd.